ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 1 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201,122 | +18.2% | 37,039 | +46.9% | 0.00% | – |
| Q2 2023 | $170,170 | -59.6% | 25,222 | -47.3% | 0.00% | -100.0% |
| Q1 2023 | $420,936 | +19.1% | 47,827 | +0.5% | 0.00% | – |
| Q4 2022 | $353,299 | -3.5% | 47,587 | -5.0% | 0.00% | -100.0% |
| Q3 2022 | $366,000 | +2.2% | 50,097 | +10.7% | 0.00% | – |
| Q2 2022 | $358,000 | -12.9% | 45,275 | +54.2% | 0.00% | – |
| Q1 2022 | $411,000 | -18.0% | 29,356 | +138.9% | 0.00% | -100.0% |
| Q2 2021 | $501,000 | +128.8% | 12,290 | +126.3% | 0.00% | – |
| Q1 2021 | $219,000 | -42.2% | 5,430 | -15.4% | 0.00% | -100.0% |
| Q4 2020 | $379,000 | -2.3% | 6,415 | -20.0% | 0.00% | 0.0% |
| Q3 2020 | $388,000 | – | 8,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |